Ridgetech, Inc. (RDGT)
NASDAQ: RDGT · Real-Time Price · USD
2.540
+0.180 (7.63%)
At close: Jan 16, 2026, 4:00 PM EST
2.590
+0.050 (1.97%)
After-hours: Jan 16, 2026, 6:47 PM EST
Ridgetech Market Cap
Ridgetech has a market cap or net worth of $46.45 million as of January 16, 2026. Its market cap has increased by 295.66% in one year.
Market Cap
46.45M
Enterprise Value
44.05M
1-Year Change
295.66%
Ranking
Category
Stock Price
$2.54
Market Cap Chart
Since September 29, 2009, Ridgetech's market cap has increased from $35.40M to $46.45M, an increase of 31.20%. That is a compound annual growth rate of 1.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 46.45M | -10.88% |
| Dec 31, 2025 | 52.11M | 376.55% |
| Dec 31, 2024 | 10.94M | 46.36% |
| Dec 29, 2023 | 7.47M | -75.52% |
| Dec 30, 2022 | 30.52M | 94.73% |
| Dec 31, 2021 | 15.67M | -59.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.82B |
| Johnson & Johnson | 528.62B |
| AbbVie | 385.11B |
| UnitedHealth Group | 305.53B |
| AstraZeneca | 291.28B |
| Novartis AG | 278.73B |
| Merck & Co. | 276.35B |
| Novo Nordisk | 252.12B |